Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2011

Open Access 01-01-2011 | Original Paper

HIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian Federation

Authors: Lauretta E. Grau, Edward White, Linda M. Niccolai, Olga V. Toussova, Sergei V. Verevochkin, Andrei P. Kozlov, Robert Heimer

Published in: AIDS and Behavior | Issue 1/2011

Login to get access

Abstract

We examined the prevalence of HIV disclosure to sexual partners by HIV-positive drug injectors (IDUs) in St. Petersburg, Russia and compared the magnitude and direction of associations of condom use with awareness of one’s HIV infection and disclosure to partners. Among 157 HIV-infected participants, awareness of infection at time of last intercourse was associated with condom use with partners perceived to be HIV-negative (aOR 6.68, 95% CI 1.60–27.88). Among the 70 participants aware of their infection prior to enrolment, disclosure to potentially uninfected sexual partners was independently and negatively associated with condom use (aOR 0.13, 95% CI 0.02–0.66). Disclosure was independently associated with having injected ≥9 years (aOR 6.04, 95% CI 1.53–23.77) and partnership with another IDU (aOR 3.61, 95% CI 1.44–9.06) or HIV-seropositive (aOR 45.12, 95% CI 2.79–730.46). Scaling up HIV testing services and interventions that increase the likelihood of individuals receiving their test results is recommended.
Literature
1.
Elovich R, Drucker E. On drug treatment and social control: Russian narcology’s great leap backwards. Harm Reduct J. 2008;5:23.CrossRefPubMed
2.
3.
4.
5.
Kozlov AP. HIV in Russia, Belorussia, and Ukraine. Russ J HIV/AIDS Relat Probl. 2000;4:11–4.
6.
Krupitsky EM, Zvartau EE, Lioznov DA, et al. Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region. Russ Eur Addict Res. 2006;12(1):12–9.CrossRef
7.
Semaille C, Alix J, Downs AM, Hamers FF. The HIV infection in Europe: large East–West disparity. Euro Surveill. 2003;8(3):57–64.PubMed
8.
9.
Abdala N, Carney JM, Durante AJ, et al. Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St. Petersburg, Russia. Int J STD AIDS. 2003;14:697–703.CrossRefPubMed
10.
Niccolai LM, Shcherbakova IS, Toussova OV, Kozlov AP, Heimer R. The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health. 2009;86(Suppl 1):131–43.CrossRefPubMed
11.
Ostrovsky D. Injection drug use, HIV, hepatitis, and overdose in St. Petersburg. In: 8th International conference on AIDS, cancer, and related problems. St. Petersburg, Russia; 2000.
12.
Ostrovsky DV. WHO drug injecting study in St. Petersburg, phase two. In: XIV International AIDS conference, Barcelona, Spain; 2002 [abstract WePeC6081].
13.
Shaboltas AV, Toussova OV, Hoffman IF, et al. HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr. 2006;41:657–63.PubMed
14.
Smol’skaia TT, Khodakevich LN, Kobyshcha IuV, et al. An HIV prevalence study by means of sentinel epidemiological surveillance among injection narcotic abusers in Saint Petersburg [Russian]. Zh Mikrobiol Epidemiol Immunobiol. 2000;4:31–3.PubMed
15.
Burchell AN, Calzavara LM, Orekhovsky V, Ladnaya NN. Canada AIDS Russia project, Russian HIV response network. Characterization of an emerging heterosexual HIV epidemic in Russia. Sex Transm Dis. 2008;35:807–13.CrossRefPubMed
16.
17.
18.
Centers of Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329–32.
19.
Janssen RS, Valdisserri RO. HIV prevention in the United States: increasing emphasis on working with those living with HIV. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S119–21.PubMed
20.
Simoni JM, Mason HR, Marks G, Ruiz MS, Richardson JL. Women living with HIV: sexual behaviors and counseling experiences. Women Health. 1995;23:17–26.PubMed
21.
Sowell RL, Lowenstein A, Moneyham L, Demi A, Mizuno Y, Seals B. Resources, stigma, and patterns of disclosure in rural women with HIV infection. Public Health Nurs. 1997;14:302–12.CrossRefPubMed
22.
Stein MD, Freedberg KA, Sullivan LM, et al. Sexual ethics: disclosure of HIV-positive status to partners. Arch Int Med. 1998;158:253–7.CrossRef
23.
Amirkhanian YA, Kelly JA, Issayev DD. AIDS knowledge, attitudes, and behaviour in Russia: results of a population-based, random-digit telephone survey in St. Petersburg. Int J STD AIDS. 2001;12:50–7.CrossRefPubMed
24.
Balabanova Y, Coker R, Atun RA, Drobniewski F. Stigma and HIV infection in Russia. AIDS Care. 2006;18:846–52.CrossRefPubMed
25.
Niccolai LM, Toussova OV, Verevochkin SV, Barbour R, Heimer R, Kozlov AP. High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav. 2010;14(4):932–41.
26.
Latka MH, Mizuno Y, YingFeng W, et al. Are feelings of responsibility to limit the sexual transmission of HIV associated with safer sex among HIV-positive injection drug users? J Acquir Immune Defic Synd. 2007;46(Supp 2):S88–95.CrossRef
27.
Niccolai LM, Dorst D, Myers L, Kissinger PJ. Disclosure of HIV status to sexual partners: predictors and temporal patterns. Sex Transm Dis. 1999;26:281–5.CrossRefPubMed
28.
DeRosa CJ, Marks G. Preventive counseling of HIV-positive men and self-disclosure of serostatus to sex partners: new opportunities for prevention. Health Psychol. 1998;17:224–31.CrossRef
29.
Knight KR, Purcell D, Dawson-Rose C, Halkitis PN, Gomez CA, Seropositive Urban Injectors Study Team. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. AIDS Educ Prev. 2005;17(Suppl A):76–88.CrossRefPubMed
30.
Perry SW, Card CA, Moffat M, Ashman R, Fishman B, Jacobsberg LB. Self-disclosure of HIV infection to sexual partners after repeated counseling. AIDS Educ Prev. 1994;6(5):403–11.PubMed
31.
Semple SJ, Patterson TL, Grant I. Psychosocial characteristics and sexual risk behavior of HIV + men who have anonymous sex partners. Psychol Health. 2004;19(1):71–87.CrossRef
32.
Semple SJ, Patterson TL, Shaw WS, Pedlow CT, Grant I. Disclosure of HIV seropositivity to sexual partners: an application of social cognitive theory. Behav Ther. 1999;30:223–37.CrossRef
33.
Wolitski RJ, Bailey CJ, O’Leary A, Gomez CA, Parsons JT. Seropositive urban men’s study (SUMS). Self-perceived responsibility of HIV-seropositive men who have sex with men for preventing HIV transmission. AIDS Behav. 2003;7(4):363–72.CrossRefPubMed
34.
35.
Garnett GP, Anderson RM. Contact tracing and the estimation of sexual mixing patterns: the epidemiology of gonococcal infections. Sex Transm Dis. 1993;20:181–91.CrossRefPubMed
36.
Gupta S, Anderson RM, May RM. Networks of sexual contact: implications for the pattern of spread of HIV. AIDS. 1989;3:807–17.CrossRefPubMed
37.
38.
Ciccarone D, Kanouse D, Collins R, et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. Am J Public Health. 2003;93(6):949–54.CrossRefPubMed
39.
Marks G, Crepaz N. HIV-positive men’s sexual practices in the context of self-disclosure of HIV status. J Acquir Immune Defic Syndr. 2001;7:866–9.
40.
Parsons JT, Missildine W, van Ora J, Purcell DW, Gomez CA. HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care STDS. 2004;18:457–69.CrossRefPubMed
41.
Derlega VJ, Winstead BA, Oldfield EC III, Barbee AP. Close relationships and social support in coping with HIV: a test of sensitive interaction systems theory. AIDS Behav. 2003;7(2):119–29.CrossRefPubMed
42.
Zea MC, Reisen CA, Poppen PJ, Diaz RM. Asking and telling: communication about HIV status among Latino HIV-positive gay men. AIDS Behav. 2003;7(2):143–52.CrossRefPubMed
43.
Cusick L, Rhodes T. The process of disclosing positive HIV status: findings from qualitative research. Cult Health Sex. 1999;1(1):3–18.CrossRef
44.
Klitzman RL. Self-disclosure of HIV status to sexual partners: a qualitative study of issues faced by gay men. J Gay Lesbian Med Assoc. 1999;3(2):39–49.CrossRef
45.
Yoshioka MR, Schustack A. Disclosure of HIV status: cultural issues of Asian patients. AIDS Patient Care STDS. 2001;15(2):77–82.CrossRefPubMed
46.
Realo A, Goodwin R. Family-related allocentrism and HIV risk behavior in Central and Eastern Europe. J Cross Cult Psychol. 2003;34(6):690–701.CrossRef
47.
Parsons JT, VanOra J, Missildine W, Purcell DW, Gomez CA. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Educ Prev. 2004;16:459–75.CrossRefPubMed
48.
Schlumberger MG, Desenclos J-C, Papaevangelou G, Richardson SC, Ancelle-Park R, European Community Study Group on HIV in Injecting Drug Users. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. Eur J Epidemiol. 1999;15:207–15.CrossRefPubMed
49.
Iguchi MY, Ober AJ, Berry S, et al. Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent driven sampling: sampling methods and implications. J Urban Health. 2009;86(Suppl 1):5–31.CrossRefPubMed
50.
Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174–99.CrossRef
51.
Heckathorn DD. Extensions of respondent-driven sampling: analyzing continuous variables and controlling for different recruitment. Sociol Methodol. 2007;37:151–208.CrossRef
52.
StataCorp. Stata statistical software: release 10. 10 ed. College Station, TX: StataCorp; 2007.
53.
Dave SS, Stephenson J, Mercey DE, Panahmand N, Jungmann E. Sexual behavior, condom use, and disclosure of HIV status in HIV infected heterosexual individuals attending an inner London HIV clinic. Sexy Transm Infect. 2006;82:117–20.CrossRef
54.
Wolitski R, Rietmeijer CA, Goldbaun GM, Wilson RM. HIV serostatus disclosure among gay and bisexual men in four American cities: general patterns and relation to sexual practices. AIDS Care. 1998;10(5):599–610.CrossRefPubMed
55.
Kalichman SC, Nachimson D. Self-efficacy and disclosure of HIV-positive serostatus to sex partners. Health Psychol. 1999;18(3):281–7.CrossRefPubMed
56.
Kral AH, Bluthenthal RN, Lorvick J, Gee L, Baccetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: rick-factor analysis. Lancet. 2001;357(9266):1397–401.CrossRefPubMed
57.
Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161(10):1281–8.CrossRefPubMed
58.
Semaan S, Des Jarlais DC, Sogolow E, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr. 2002;30(Suppl 1):S73–93.PubMed
59.
Raj A, Cheng DM, Krupitsky EM, Coleman S, Bridden C, Samet JH. Correlates of any condom use among Russian narcology patients reporting recent unprotected sex. AIDS Behav. 2009;13:210–7.CrossRef
60.
Bobrova N, Sergeev O, Grechukhina T, Kapiga S. Social-cognitive predictors of consistent condom use among young people in Moscow. Perspect Sex Reprod. 2005;37:174–8.CrossRef
61.
Gerber TP, Berman D. Heterogeneous condom use in contemporary Russia. Stud Fam Plann. 2008;39:1–17.CrossRefPubMed
62.
Anderson JE, Cheney R, Clatts M, Faruque S, Kipke M, Long A, et al. HIV risk behavior, street outreach, and condom use in eight high-risk populations. AIDS Educ Prev. 1996;8:191–204.PubMed
63.
Belanger D, Godin G, Alary M, Bernard P-M. Factors explaining the intention to use condom among injecting drug users participating in a needle-exchange program. J Appl Soc Psychol. 2002;32:1047–63.CrossRef
64.
Bogart LM, Kral AH, Scott A, Anderson R, Flynn N, Gilbert ML, et al. Condom attitudes and behaviors among injection drug users participating in California syringe exchange programs. AIDS Behav. 2005;9:423–32.CrossRefPubMed
65.
Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58:219–26.CrossRefPubMed
66.
Shafer KP, Hahn JA, Lum PJ, Ochoa K, Graves A, Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J Acquir Immune Defic Syndr. 2002;31:422–31.PubMed
67.
Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, et al. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS. 1993;7:887–91.CrossRefPubMed
68.
White D, Phillips K, Mulleady G, Cupitt C. Sexual issues and condom use among injecting drug users. AIDS Care. 1993;5:427–37.CrossRefPubMed
Metadata
Title
HIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian Federation
Authors
Lauretta E. Grau
Edward White
Linda M. Niccolai
Olga V. Toussova
Sergei V. Verevochkin
Andrei P. Kozlov
Robert Heimer
Publication date
01-01-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9775-z

Other articles of this Issue 1/2011

AIDS and Behavior 1/2011 Go to the issue

Original Paper

Racial/Ethnic Differences in Seroadaptive and Serodisclosure Behaviors Among Men Who Have Sex with Men

Original Paper

HIV and Related Risk Behavior Among Men Who Have Sex with Men in Zanzibar, Tanzania: Results of a Behavioral Surveillance Survey

Original Research

Spousal Intimate Partner Violence is Associated with HIV and Other STIs Among Married Rwandan Women

Original Paper

Intimate Partner Violence Perpetration and Condom Use-Related Factors: Associations with Heterosexual Men’s Consistent Condom Use

ORIGINAL PAPER

Sexual Mixing and Condom Use with Different Types of Sex Partners among Non-Institutionalized Sexually Active Female Injecting Drug Users in Sichuan, China

Original Paper

History of Sexual Trauma and Recent HIV-Risk Behaviors of Community-Recruited Substance Using Women
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits